After parting ways with its diabetes franchise nearly three years ago, BD is slimming down even further with a plan to divest its diagnostic and biosciences businesses as the company nears the finish ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced that it has completed the previously disclosed ...

In its Q1 fiscal 2026 financials, BD trimmed its EPS outlook by more than $2 at the high end due to the spin-off of its ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced the commercial launch of the BD Vacutainer Urine ...

No, it’s not an April Fool’s joke—BD officially bid farewell to its longstanding diabetes business on Friday, as the newly formed Embecta made its public debut on the Nasdaq. The separation was nearly ...

BD (Becton, Dickinson and Company) has agreed to combine its biosciences and diagnostic solutions business with Waters Corporation, creating a new life science and diagnostics company. The agreement ...

Medical tech company BD (Becton, Dickinson and Co.) acquired MedKeeper, a provider of cloud-based pharmacy management applications, the Franklin Lakes firm announced July 28. The deal – terms of which ...

BD’s new MiniDraw diagnostic devices could let pharmacists—and, one day, maybe patients—manage blood testing needs and monitor health conditions. BD received its FDA authorizations for two blood draw ...

FRANKLIN LAKES, N.J. - BD (Becton, Dickinson and Company) (NYSE:BDX) announced Wednesday the appointment of Shawn Bevec as senior vice president of investor relations, effective January 20. The ...

The Parata Systems team will work with BD’s medication management solutions business, according to a July 18 news release. The company plans to focus on issues including clinician shortages, wage ...